209,734 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Acquired by St. James Investment Company LLC

St. James Investment Company LLC acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 209,734 shares of the company’s stock, valued at approximately $16,397,000. GE HealthCare Technologies accounts for about 2.8% of St. James Investment Company LLC’s investment portfolio, making the stock its 17th largest position.

A number of other institutional investors have also made changes to their positions in the company. CoreFirst Bank & Trust purchased a new position in GE HealthCare Technologies in the fourth quarter valued at about $25,000. Runnymede Capital Advisors Inc. acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth approximately $28,000. Continuum Advisory LLC increased its stake in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after buying an additional 168 shares during the last quarter. Bank of Jackson Hole Trust acquired a new stake in GE HealthCare Technologies in the fourth quarter valued at $32,000. Finally, OFI Invest Asset Management bought a new position in GE HealthCare Technologies during the 4th quarter valued at $34,000. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Down 2.0 %

NASDAQ:GEHC opened at $80.01 on Monday. The stock has a market cap of $36.59 billion, a price-to-earnings ratio of 18.48, a PEG ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80. The business has a fifty day moving average of $86.70 and a 200-day moving average of $85.86.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.17%. GE HealthCare Technologies’s payout ratio is 3.23%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on GEHC shares. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and upped their target price for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.